Leucosis: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 33: | Line 33: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 17:37, 17 March 2025
Leucosis is a term used to describe a group of cancerous diseases characterized by the overproduction of white blood cells (leukocytes) in the bone marrow. It is a type of hematological malignancy, which includes a wide range of conditions from leukemia to lymphoma and myeloma.
Etiology[edit]
The exact cause of leucosis is not known, but it is believed to involve a combination of genetic and environmental factors. Some studies suggest that exposure to certain chemicals, radiation, and some viral infections may increase the risk of developing leucosis.
Symptoms[edit]
Symptoms of leucosis can vary depending on the type and stage of the disease. Common symptoms include fatigue, frequent infections, unexplained weight loss, easy bruising or bleeding, and bone pain or tenderness.
Diagnosis[edit]
Diagnosis of leucosis typically involves a series of tests, including blood tests, bone marrow tests, and imaging tests. The goal of these tests is to determine the type of leucosis and its stage, which can help guide treatment decisions.
Treatment[edit]
Treatment for leucosis depends on the type and stage of the disease, as well as the patient's overall health. Treatment options may include chemotherapy, radiation therapy, stem cell transplant, or targeted therapy.
Prognosis[edit]
The prognosis for leucosis varies widely depending on the type and stage of the disease, as well as the patient's overall health. Some forms of leucosis can be cured with treatment, while others may be chronic and require ongoing management.
See also[edit]
